Acro Biomedical Co. Ltd. engages in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. The company is headquartered in Fishers, Indiana. The company went IPO on 2016-06-23. The firm is focused on developing and marketing nutritional products that promote wellness and a healthy lifestyle. The firm's business consists of selling cordyceps related products that is used in traditional Chinese medicine. Cordyceps is a fungus which is a combination of a caterpillar and a fungus, which is found at altitudes above 4500 meters (m) in Sikkim. The firm is engaged in the purchase of products from three suppliers in Taiwan and the sale of these products to four unrelated customers. The company sells products in bulk to companies who may use the Company's products as ingredients in their products or sell the products they purchase from the Company to their own customers.
ACBM stock price ended at $0.03 on 星期二, after rising 0.00%
On the latest trading day Jun 16, 2026, the stock price of ACBM rose by 0.00%, climbing from $0.03 to $0.03. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.03 and a high of $0.03. Notably, trading volume dropped by 105 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 260 shares were traded, equating to a market value of approximately $1.8M.